Abstract

Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdominal cavity is the first barrier encountered by OvCA cells. Subsequent progression of tumors through the peritoneum leads to the accumulation into the peritoneal stroma of a sizeable population of carcinoma-associated fibroblasts (CAFs), which is mainly originated from a mesothelial-to-mesenchymal transition (MMT) process. A common characteristic of OvCA patients is the intraperitoneal accumulation of ascitic fluid, which is composed of cytokines, chemokines, growth factors, miRNAs, and proteins contained in exosomes, as well as tumor and mesothelial suspended cells, among other components that vary in proportion between patients. Exosomes are small extracellular vesicles that have been shown to mediate peritoneal metastasis by educating a pre-metastatic niche, promoting the accumulation of CAFs via MMT, and inducing tumor growth and chemoresistance. This review summarizes and discusses the pivotal role of exosomes and MMT as mediators of OvCA peritoneal colonization and as emerging diagnostic and therapeutic targets.

Highlights

  • Introduction314,000 new cases of ovarian cancer (OvCA) were diagnosed in 2020, with over 207,000 disease-related deaths

  • Worldwide, 314,000 new cases of ovarian cancer (OvCA) were diagnosed in 2020, with over 207,000 disease-related deaths

  • This review focuses on providing novel insights to understand how exosomes participate in OvCA progression through the peritoneum

Read more

Summary

Introduction

314,000 new cases of ovarian cancer (OvCA) were diagnosed in 2020, with over 207,000 disease-related deaths. Malignant ascites is the result of leakiness of microvasculature, as well as obstruction of lymphatic vessels, and is frequently a sign of peritoneal affectation [22,23,24] Within this intraperitoneal fluidic microenvironment, tumor cells, mesothelial-derived CAFs, and infiltrating leukocytes produce a multitude of factors, including but not limited to cytokines, chemokines, and growth factors [15,23,25,26,27,28]. The content of exosomes shows specificity peritoneal affectation [22,23,24] Within this intraperitoneal fluidic microenvironment, to the cell of origin and depends, as well, on the functional state and regulated sorting tumor cells, mesothelial-derived CAFs, and infiltrating leukocytes produce a multitude of mechanisms of the cell, common components have been described for exosomes released by factors, including but not limited to cytokines, chemokines, and growth factors [15,23,25–. The new knowledge related to exosomes as potential biomarkers and therapeutic tools for peritoneal metastasis in OvCA will be briefly discussed

The role of Exosomes in Ovarian Cancer Peritoneal Metastasis
Peritoneal Mesothelial Cells
Effects
Effects of Oncosomes on Ovarian Cancer Cells
Effects of Oncosomes on Endothelial Cells
CAFs Generated via MMT Produce Exosomes That Impact on Recipient Target
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call